Darbagen
Generic Name
Darbepoetin alfa
Manufacturer
Incepta Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| darbagen 40 mcg injection | ৳ 4,500.00 | N/A |
Description
Overview of the medicine
Darbepoetin alfa is an erythropoiesis-stimulating protein. It is used to treat anemia associated with chronic kidney disease (CKD) and anemia in cancer patients receiving chemotherapy.
Uses & Indications
Dosage
Adults
For CKD: Initial 0.45 mcg/kg IV/SC weekly or 0.75 mcg/kg every 2 weeks. For chemotherapy: Initial 2.25 mcg/kg SC weekly or 500 mcg SC every 3 weeks. Dosing is individualized based on hemoglobin levels.
Elderly
No specific dosage adjustment needed, but monitor closely due to potential comorbidities.
Renal_impairment
Primary indication for treatment; dosage adjusted based on hemoglobin response.
How to Take
Administered by subcutaneous (SC) or intravenous (IV) injection. Do not shake the syringe.
Mechanism of Action
Darbepoetin alfa stimulates erythropoiesis by the same mechanism as endogenous erythropoietin, increasing red blood cell production.
Pharmacokinetics
Onset
Hemoglobin levels typically begin to rise within 2-6 weeks.
Excretion
Primarily via catabolism; minimal renal excretion.
Half life
Approximately 25-49 hours (IV) and 49 hours (SC).
Absorption
Slow and complete absorption after subcutaneous administration. Bioavailability approximately 37% (SC).
Metabolism
Catabolized like endogenous proteins.
Side Effects
Contraindications
- •Uncontrolled hypertension.
- •Pure Red Cell Aplasia (PRCA) unrelated to erythropoietin treatment.
- •Serious allergic reactions to Darbepoetin alfa.
Drug Interactions
No significant drug interactions
No specific drug interactions have been reported for Darbepoetin alfa. However, patients should inform their doctor about all medications they are taking.
Storage
Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Overdose
Overdose can lead to polycythemia. Management involves symptomatic and supportive treatment. Phlebotomy may be performed if polycythemia develops.
Pregnancy & Lactation
Pregnancy Category C. Use only if potential benefit justifies potential risk to fetus. It is unknown if Darbepoetin alfa is excreted in human milk; caution should be exercised when administered to a nursing woman.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
Typically 24-36 months, check manufacturer's label for exact expiry.
Availability
Hospitals, Clinics, Pharmacies
Approval Status
Approved (DGDA, FDA)
Patent Status
Off-patent (active ingredient)
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
More Medicines
Explore other medicines you might be interested in
